Scan Results
Daily timeframeEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa,. The $2.08B market capitalization puts ESTA squarely in mid-cap range for its industry. The company offers silicone gel-filled breast implants under the Motiva Implants brand.
Market Cap
$2.08B
Beta
1.12
P/E (TTM)
—
P/E (Fwd)
942.53
EPS (TTM)
$-1.47
EPS (Fwd)
$0.07
ROE
-164.0%
ROA
-5.2%
Cash
$68.1M
Total Debt
$264.0M
Free CF
-$27.8M
52W Change
108.1%
Annual Financials
Cash vs Debt
The company holds $68.1M in cash, though total debt stands at $264.0M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow is running at -$27.8M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -164.0%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $161.7M (2022) to $211.1M (2025), reflecting a 31% increase over the period.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Establishment Labs Holdings Inc.'s trajectory.